Y-mAbs Therapeutics, Inc.

NASDAQ:YMAB

15.55 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Operating Activities:
Net Income -6.998-9.249-6.629-0.988-7.747-6.302-6.391.157-27.526-41.131-28.068-36.893-28.858-22.93733.413-19.933-32.832-40.393-26.179-23.136-23.922-18.036-15.934-14.06-11.426-10.305-7.483-9.254-3.826-3.041-3.041
Depreciation & Amortization 0.1210.1530.1590.1610.1680.2240.1820.230.2260.1880.1950.2910.1450.2160.130.1170.0930.10.0860.0790.0480.020.0190.0140.0090.00600000
Deferred Income Tax 000-3.3342.281.054000000000.4350000000000000000
Stock Based Compensation 4.1953.4393.8463.1232.4953.6165.3043.5393.34113.6335.0914.9084.9014.8274.6988.3363.1342.4542.2111.4771.3450.9710.8640.4950.3950.9040.1720.1630.1510.1480.148
Change In Working Capital -4.3785.723-1.345-9.4423.426-1.954-11.764-13.4642.7592.788-2.454-3.3155.498-0.94-8.527-5.7015.4561.5882.101-2.91913.0671.517-0.0221.812-2.5230.6862.7921.049-0.23-0.23
Accounts Receivables 18.3-17.6281.866-3.580.244-0.416-6.171-3.28-2.0432.116-1.612-0.4481.253-2.52-5.997-11.816000000000000000
Change In Inventory -1.059-0.05-3.3832.048-1.9263.758-2.243-0.460.552-1.206-0.076-0.725-0.967-2.815-1.0057.376000000000000000
Change In Accounts Payables -1.1323.230.176-0.66-0.047-1.378-4.771-1.092.432-3.371.1092.5284.2210.26-2.829-0.9480.495-0.4351.741.586-1.9843.149-0.134-0.4392.068-1.6011.2332.0680.95300
Other Working Capital -20.16720.171-0.004-7.255.155-3.9181.421-8.6341.8185.248-1.875-4.670.9914.1351.304-0.3134.9612.0230.361-4.5052.984-0.0821.6510.417-0.256-0.922-0.5470.7240.096-0.23-0.23
Other Non Cash Items -3.60518.4255.9972.444-1.875-1.372-0.456-0.1211.9651.4220.3111.1460.2380.078-62.01-0.5140.0048.6160.025-0.080.134-0.0620.051-0.0040.0220.0620.017-0.01-0.053-0.318-0.318
Operating Cash Flow -10.6650.298-3.477-8.036-1.338-4.734-13.124-8.661-19.235-23.1-24.925-33.863-18.076-18.756-31.861-17.695-24.145-27.635-21.756-24.579-21.395-14.04-13.483-13.577-9.188-11.856-6.608-6.309-2.679-3.441-3.441
Investing Activities:
Investments In Property Plant And Equipment 00000000000-0.455-0.071-0.041-0.4-0.044-0.103-0.002-0.026-1.147-0.617-0.075-0.126-0.057-0.053-0.12400000
Acquisitions Net 0000000000000000000000000000000
Purchases Of Investments 0000000000000000000000000000000
Sales Maturities Of Investments 0000000000000000000000000000000
Other Investing Activites 00000000000-0.30062.010-2.6100000000000000
Investing Cash Flow 0000000-0.032000-0.455-0.071-0.04161.61-0.044-2.713-0.002-0.026-1.147-0.617-0.075-0.126-0.057-0.053-0.1240-0.0280.02800
Financing Activities:
Debt Repayment 0000000000000000000000000000000
Common Stock Issued -2.3461.7580.5880.100000.05200.0320.10.2480.131107.7250000134.704000-1.84200065.38614.32100
Common Stock Repurchased 00000000000000000000000-1.8420000000
Dividends Paid 0000000000000000000000000000000
Other Financing Activities 3.3251.7580.5880.100000.05200.0320.10.2480.1310.111.4190.21500.37134.704000-101.607102.373-0.127-1.641-0.249-0.0095.0695.069
Financing Cash Flow 0.9791.7580.5880.100000.05200.0320.10.2480.131107.8351.4190.21500.37134.704000-1.842102.373-0.127-1.64165.13714.3125.0695.069
Other Information:
Effect Of Forex Changes On Cash 0.0020.0010.0010.00200.014-0.009-0.1030.0440.0410.0530.0520.042-0.0180.053-0.313-0.149-0.0780.05-0.0340.0410.0030.0130.0240.0070.045-0.02-0.0370.004-0.038-0.038
Net Change In Cash -9.6842.057-2.888-7.934-1.338-4.72-13.133-8.764-19.139-23.059-24.84-34.166-17.857-18.684137.637-16.633-26.792-27.715-21.362108.944-21.971-14.112-13.596-15.45293.171-12.094-8.26958.76311.6651.591.59
Cash At End Of Period 68.12277.80675.74978.63786.57187.90992.629105.762114.526133.665156.724181.564215.73233.587252.271114.634131.267158.059185.774207.13698.192120.163134.275147.871163.32370.15282.24690.48331.7220.0551.59